Document Detail


The CT flare response of metastatic bone disease in prostate cancer.
MedLine Citation:
PMID:  21498309     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background New or worsening bone lesions in patients responding to treatment, known as the flare phenomenon is well described on (99m)Tc-MDP bone scintigraphy, but to our knowledge has not previously been described on CT. The appearance of new or worsening bone sclerosis on CT in patients with prostate cancer may therefore be erroneously classified as disease progression. Purpose To assess the incidence of osteoblastic healing flare response at 3-month CT assessment in patients with castrate-resistant prostate cancer and to identify associated features that enable differentiation from progressive metastatic bone disease at 3 months. Material and Methods CT scans of 67 patients with castrate-resistant prostate cancer undergoing treatment were reviewed by a radiologist blinded to clinical outcome. Changes in number, size, and density of metastatic bone lesions were documented and Response Evaluation Criteria in Solid Tumours (RECIST) in soft tissue lesions, alkaline phosphatase, prostate specific antigen, and (99m)Tc-MDP bone scans were used for correlation. Results Of the 39 patients who had 3- and 6-month follow-up, eight patients (21%) demonstrated an increase in number, size, or density of sclerotic lesions on the 3-month CT scan despite improvement in PSA and soft tissue lesions. Three out of eight patients (8%) maintained partial response/remained stable at follow-up and were defined as showing a flare response: in this group bone metastases evident on CT showed a qualitative and quantitative increase in density and no lesions faded at 3 months. In contrast, in all patients who progressed at 3 months by PSA/RECIST criteria (n = 8) bone lesions showed a mixed pattern with some lesions increasing and others decreasing in density. Conclusion The incidence of flare response of metastatic bone disease evident at 3-month post-treatment CT in patients with prostate cancer undergoing systemic treatment is 8%. In patients with falling PSA and stable/responding soft tissue disease at 3 months an increase in bone sclerosis in the absence of fading bone metastases can be interpreted as flare and is likely to represent a response.
Authors:
Christina Messiou; Gary Cook; Alison Hm Reid; Gerhardt Attard; David Dearnaley; Johann S de Bono; Nandita M de Souza
Related Documents :
12438059 - Two-station bolus-chase mr angiography with a stationary table: a simple alternative to...
12362069 - Eight-channel multidetector computed tomography: unique potential for pediatric chest c...
19341899 - Setting up an imaging center, adding ct, mr, [corrected] and an angiography suite to va...
20479649 - Intravascular functional maps of common neurovascular lesions derived from volumetric 4...
9668179 - Imaging of intracranial aneurysms and subarachnoid hemorrhage.
15290489 - Two cases of pseudoaneurysm of the renal artery following laparoscopic partial nephrect...
15201949 - Preoperative localization of parathyroid glands. use of mri, scintigraphy, and image fu...
18574759 - Morphological changes of the lower cervical spinal cord under neutral and fully flexed ...
7178979 - The value of computed tomography in spinal trauma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-23
Journal Detail:
Title:  Acta radiologica (Stockholm, Sweden : 1987)     Volume:  -     ISSN:  1600-0455     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-4-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706123     Medline TA:  Acta Radiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Double reading of radiological examinations in Norway.
Next Document:  Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor fro...